Mobile

Combined Alternating Sunitinib and Bevacizumab (Avastin®) in Advanced Renal Cell Carcinoma (CASA)

Update Il y a 4 ans
Reference: NCT02919371

Woman and Man

  • | Country :
    • -
  • | organs :
    • -
  • | Specialty :
    • -

Extract

Combined sunitinib and bevacizumab in advanced renal cell carcinoma.

Inclusion criteria

  • Renal Cell Carcinoma

Links